Caitlin E. Billiot

Caitlin E. Billiot

Auto-generated profile, based on publicly available information

Caitlin E. Billiot

Department of Medicine, Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
MMMelissa S. McDaniel
Melissa S. McDaniel
NLNatalie R. Lindgren
Natalie R. Lindgren
CBCaitlin E. Billiot
Caitlin E. Billiot
KVKristina Nicole Valladares
Kristina Nicole Valladares
NSNicholas A. Sumpter
Nicholas A. Sumpter
WSW. Edward Swords
W. Edward Swords
Despite advances in treatment options for people with CF, complications of bacterial infections remain the greatest driver of morbidity and mortality in this patient population. These infections often involve more than one bacterial pathogen, and our understanding of how interspecies interactions impact disease progression is lacking.

12 December 2023 in Infection and Immunity
Verified
Journal Article
Closed access
CBCaitlin E. Billiot
Caitlin E. Billiot
LNLea Novak
Lea Novak
MMMelissa S. McDaniel
Melissa S. McDaniel
NLNatalie R. Lindgren
Natalie R. Lindgren
WSW. Edward Swords
W. Edward Swords
Cystic fibrosis (CF) is a genetic disease affecting epithelial ion transport, resulting in thickened mucus and impaired mucociliary clearance. Persons with CF (pwCF) experience life-long infections of the respiratory mucosa caused by a diverse array of opportunists, which are leading causes of morbidity and mortality. In recent years, there has been increased appreciation for the range and diversity of microbes causing CF-related respiratory infections. The introduction of new therapeutics and improved detection methodology has revealed CF-related opportunists such as Achromobacter xylosoxidans ( Ax ). Ax is a Gram-negative bacterial species which is widely distributed in environmental sources and has been increasingly observed in sputa and other samples from pwCF, typically in patients in later stages of CF disease. In this study, we characterized CF clinical isolates of Ax and tested colonization and persistence of Ax in respiratory infection using immortalized human CF respiratory epithelial cells and BALB/c mice. Genomic analyses of clinical Ax isolates showed homologs for factors including flagellar synthesis, antibiotic resistance, and toxin secretion systems. Ax isolates adhered to polarized cultures of CFBE41o- human immortalized CF bronchial epithelial cells and caused significant cytotoxicity and depolarization of cell layers. Ax colonized and persisted in mouse lungs for up to 72 h post infection, with inflammatory consequences that include increased neutrophil influx in the lung, lung damage, cytokine production, and mortality. We also identified genes that are differentially expressed in synthetic CF sputum media. Based on these results, we conclude that Ax is an opportunistic pathogen of significance in CF.